Yahoo Web Search

Search results

  1. BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. Learn more.

    • Our Treatments

      Products and Pipeline. For more than two decades, we have...

    • Our Company

      BioMarin is a global biotechnology company that relentlessly...

    • Diseases & Conditions

      Learn more about the clinical trials BioMarin is conducting...

    • Products

      We provide eight important treatment options for people...

  2. BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs).

  3. Feb 22, 2024 · BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024. February 22, 2024. Total FY'23 Revenues of $2.42 Billion (+15% Y/Y and +20% Y/Y at Constant Currency); GAAP Diluted Earnings per Share of $0.87 (+16% Y/Y) and Non-GAAP Diluted Earnings per Share of $2.08 (+36% Y/Y ...

  4. People also ask

  1. People also search for